$2.65
-0.1-3.64%
Last update: 9:40 AM
15 minutes delayed
Comments
Loading...
Geovax Labs (NASDAQ:GOVX) Stock Quotes, Forecast and News Summary
Geovax Labs Stock (NASDAQ: GOVX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Geovax Labs (GOVX) stock?
You can purchase shares of Geovax Labs (NASDAQ:GOVX) through any online brokerage.
Who are Geovax Labs (GOVX) competitors?
Other companies in Geovax Labs’s space includes: Vincerx Pharma (NASDAQ:VINC), Burning Rock Biotech (NASDAQ:BNR), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and Palatin Techs (AMEX:PTN).
What is the forecast, or price target, for Geovax Labs (GOVX) stock?
Geovax Labs has a consensus price target of $10.29.
What is the current price for Geovax Labs (GOVX)?
The stock price for Geovax Labs (NASDAQ: GOVX) is $2.78 last updated September 25, 2024 at 9:22 AM EDT.
Does Geovax Labs (GOVX) pay a dividend?
There are no upcoming dividends for Geovax Labs.
When is Geovax Labs (NASDAQ:GOVX) reporting earnings?
Geovax Labs’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Geovax Labs (GOVX) going to split?
There is no upcoming split for Geovax Labs.
What sector and industry does Geovax Labs (GOVX) operate in?
Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.